Pharmalot… Pharmalittle… The Weekend Nears
3 CommentsBy Ed Silverman // December 3rd, 2010 // 7:36 am
Once again, another work week is about to draw to a close. Although meetings and deadlines loom today, already we are looking ahead to spending time with the short people, a night at the movies, catching up on some reading and promenading with the official Pharmalot mascots. What about you? Anything special planned? Maybe an afternoon nap or a fancy dinner? Well, you could always pay some bills. In any event, here are a few tidbits to peruse while you consider the possibilities. Whatever you do, have a great time and stay safe. See you soon…
Pharma Mergers Scrutinized In Insider Trading Probe (Reuters)
Merck Pays $500 For SmartCell Diabetes Drugmaker (Bloomberg News)
FDA Panel Backs AstraZeneca Thyroid Drug (MedPage Today)
Licensing Deal Threatends Cheap AIDS Meds For Poor (The Independent)
Alnylam Wins RNA Patent Dispute In Europe (Associated Press)
Bayer Expands Cancer Research In Singapore (Pharma Times)
University of Missouri And Shasun Pharma Strike Research Deal (Kansas City Star)
SXC Buys Medfusion For $100M (Winnipeg Free Press)
@Pharmalot
The second headline should be corrected (”Merck pays $500 for SmartCell Diabetes Drugmaker”). $500 million maybe? Otherwise Merck got a super-bargain!
John English
For the sake of full disclosure (and an attempt at humor), is the canine pictured today a certifed companion or therapy dog? Or simply a dedicated and talented amateur?
industry insider
The ultimate treatment for medullary thyroid carcinoma will be targeted gene therapy.
http://www.thyroid.org/ann_mtg/2003_75th/documents/004_Spitweg.pdf